<DOC>
	<DOCNO>NCT00645203</DOCNO>
	<brief_summary>To evaluate safety efficacy cefdinir oral suspension child 6 month 4 year age , acute otitis medium , risk persistent recurrent otitis medium .</brief_summary>
	<brief_title>Safety Efficacy Study Cefdinir Oral Suspension , Pediatric Subjects Treat Acute Otitis Media</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Cefdinir</mesh_term>
	<mesh_term>Cephalosporins</mesh_term>
	<criteria>Male female child 6 month 4 year age Weight exceed 40 kg Clinical diagnosis acute otitis medium Have evidence middle ear fluid At risk persistent recurrent otitis medium Generally good health Sensitivity allergy penicillin cephalosporins inability take oral medication Presence tympanostomy tube , ventilation tube perforate tympanic membrane , either ear Treatment antiinfective agent within 3 day prior study treatment longacting injectable antimicrobial agent ( e.g . , penicillin G benzathine ) within 4 week prior study Concomitant infection , require additional antimicrobial therapy Presence disease , complicate factor ( e.g. , mastoiditis ) , structural abnormality would preclude evaluation patient 's therapeutic response</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>4 Years</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>